AGP Picks
View all

Entertainment Wire Massachusetts: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Entertainment Wire Massachusetts.

Press releases published on June 8, 2026

Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
Factorial Lists on Nasdaq, Bringing Solid-State Batteries From Validation to Scale
Napster Launches NV2: A Real-Time Conversational Video Model That Democratizes Access To Multimodal Agents
Fat Brain Toys Introduces Viral UK Puzzle Line “Can You Solve Me?” to U.S. Retailers
Alkeus Pharmaceuticals Announces First Patient Dosed in Pivotal Global Phase 3 NORTHSTAR Study of Oral Gildeuretinol in Stargardt Disease
Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China
Telitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in China
Questex’s Fierce Life Sciences Announces the 2026 Partnerships with Sites Summit Agenda
Oscar-Winning ‘March of the Penguins’ Producer Debuts Cricket Documentary on Willow TV
Notified Unveils Agentic Event Reporting at NIRI 2026 to Help IR Teams Track Real-Time Market Signals
Global Mofy’s Mofy Clip Co-Invests in and Produces Two AI-Powered Micro-Drama Series with Hongguo in TikTok’s Parent Company ByteDance’s Ecosystem
Zhihu Inc. to Hold Annual General Meeting on June 30, 2026
Thriving in Place: HomeSight® Expands Offerings with New Engagement Experiences, Smart Home Insights, and Nationwide Professional Installation
Zevra Therapeutics Announces Orange Book Listing of U.S. Patent Strengthening Exclusivity for MIPLYFFA
Standard BioTools and Treeline Biosciences Announce Merger Agreement
The Global Sustainability Awards Spotlights People-Driven Change
Even AI won’t tolerate a ruthless negotiator
Kymera Therapeutics Presents New Preclinical Lupus Data for KT-579, First-in-Class, Oral IRF5 Degrader, at EULAR and FOCIS Congresses
Upstream Bio to Showcase Additional Efficacy Data from the Phase 2 VIBRANT Trial of Verekitug in CRSwNP in Oral Session at EAACI 2026
Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Entertainment Wire Massachusetts

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.